These findings supply a novel mechanism for the resistance of liver cancer cell to glutamine deprivation, and also identify mTORC2 and GS as the promising prognosis biomarkers for hepatocellular carcinomas. The gene discussed is GLUL; the disease is hepatocellular carcinoma.